Cityblock Health is a New York-based, technology-driven healthcare company that delivers integrated primary care, behavioral health, and social services to Medicaid and dually eligible (Medicare-Medicaid) members in underserved communities. Spun out of Alphabet's Sidewalk Labs in 2017, Cityblock pairs neighborhood-based care teams with a custom care-management platform to treat the whole person - medical needs alongside housing, food, and other social drivers of health - under value-based, risk-sharing contracts with health plans. It serves more than 100,000 members across over ten states.
Curavit Clinical Research is a Boston-based, all-virtual Contract Research Organization (CRO) that designs and runs decentralized clinical trials. Through its Virtual Clinical Site and STRATUS platform, Curavit recruits, enrolls, and monitors diverse patient populations remotely - eliminating physical site infrastructure and travel while improving data quality. The company specializes in trials for digital therapeutics (DTx) and partners with sponsors and existing CROs to fix the execution layer of clinical research, accelerating timelines and lowering costs.
Anthony Costello is the CEO of Medidata Solutions, a Dassault Systèmes company, and one of clinical research technology's most seasoned architects. With nearly 30 years in the field, he started as a data manager at Genentech, co-founded two companies (Nextrials and Mytrus), and was acquired by Medidata before rising to lead it. Today he oversees over 8,000 active clinical studies globally each year, championing AI-driven trial innovation, decentralized models, and patient-centric design at the White House Clinical Trials Forum and beyond.
Bobn L is the Chief Executive Officer of GoodRx, the Santa Monica-based digital health company that has become America's most-used prescription savings platform. GoodRx tracks drug prices across 75,000+ pharmacies nationwide, delivering coupons and transparency to millions of Americans navigating the opaque world of prescription pricing. Under executive leadership, GoodRx has grown to nearly $800 million in annual revenue, gone public on Nasdaq (GDRX), and expanded into telemedicine - all in service of a single idea: that patients deserve to know what their medications actually cost.
House Rx is a San Francisco-based healthcare technology company that partners with specialty clinics to enable medically integrated dispensing (MID) - a model where physicians, pharmacists, nurses, and care coordinators work together as one unified team. Founded in 2021 by Flatiron Health veterans Ogi Kavazovic and Tesh Khullar, the company builds AI-enabled pharmacy management software that keeps specialty medications dispensed at the point of care, cutting average time-to-therapy from 15.5 days to 3.5 days and achieving 95% medication adherence. With $100M raised across Seed, Series A, and Series B rounds, House Rx serves 80 clinic sites, 1,000+ providers, and nearly 61,000 patients, processing approximately $1.5 billion in specialty prescriptions annually.
Brent Dover is the CEO of Carta Healthcare, an AI-powered clinical data management platform that serves hospitals and health systems nationwide using a 'Hybrid Intelligence' model combining AI with human expert abstractors. With over 20 years of healthcare technology leadership, Dover has presided over company-defining exits and growth events - including leading Medicity to a $500M acquisition by Aetna generating 16x investor returns, scaling Health Catalyst toward a NASDAQ IPO, and growing Commure to a $3.5B valuation. He joined Carta Healthcare in December 2023 and has since driven 2x revenue growth, 100% customer retention, and a $18.25M Series B1 round led by UPMC Enterprises.
Derek Chung is a software engineer at Abridge, the AI-powered clinical documentation company backed by Andreessen Horowitz with over $907M in total funding. A Stanford-trained computer scientist and accomplished concert pianist, he co-founded 88Keys to Cure, a nonprofit merging classical music with charitable causes, and has performed at Carnegie Hall's Weill Recital Hall, Chicago Symphony Orchestra Hall, and Ravinia. His career sits at a rare intersection: elite competitive piano, rigorous CS training, and building technology that reduces clinician burnout at scale.
Karim Karti is the CEO of RapidAI, a deep clinical AI company whose platform is used in 2,500+ hospitals across 100+ countries for stroke, vascular, and radiology workflows. He brings 22+ years from GE Healthcare — including running its $9B imaging division — and a stint as COO of iRhythm, where he doubled revenues to $210M in 18 months. Trained as an engineer in France and a former P&G brand manager, he now leads one of the most clinically validated AI platforms in medicine, backed by 700+ published studies and 10+ million scans processed.
Keith Carter is a healthcare technology operator with deep roots in medical imaging and surgical data infrastructure. Currently VP of Implementations & Integrations at Caresyntax - the AI-powered surgical intelligence platform used in 3,500+ operating rooms worldwide - he also serves as CEO of Cloud9PACS.com, a digital PACS system he built from the ground up. Carter's career traces the arc of healthcare IT: from PACS architect at Medlink to running his own imaging solutions company, to joining one of the most-funded surgical AI ventures in the industry. He is based in Hattiesburg, Mississippi.
Ogi Kavazovic is the co-founder and CEO of House Rx, a San Francisco-based specialty pharmacy platform that enables clinical practices to dispense specialty medications directly to patients in-house. A serial operator who helped scale Opower (acquired by Oracle) and Flatiron Health (acquired by Roche), Ogi pivoted to fix a problem he kept seeing: patients leaving the doctor's office only to get lost in a broken specialty pharmacy system. House Rx has raised $100 million in total, including a $55 million Series B in November 2025, and now processes approximately $1.5 billion in specialty scripts annually across 80+ clinic sites.
Pranay Kapadia is the Co-Founder and CEO of Notable, an AI-powered automation platform for healthcare that eliminates administrative burden for clinicians and health systems. Founded in 2017 after dinner-table conversations with six physician family members - including his psychiatrist wife who called herself 'the highest paid data collector in the world' - Notable has grown to serve 32 million patients across 12,000 sites of care, raised $119.2M in funding including a $100M Series B in 2021, and now automates over one million repetitive healthcare workflows daily. Before Notable, Kapadia helped build Mint.com at Intuit and was on the founding team at Blend, the mortgage fintech unicorn.
Sach Jain is the Founder & CEO of Carrum Health, a San Francisco-based value-based care platform that connects self-insured employers with top-tier hospitals and surgical centers through bundled payment arrangements. Founded in 2014 after Jain's frustration with America's fee-for-service healthcare system, Carrum Health has raised $96M in total funding and now covers 90% of the US population through a network that includes Mayo Clinic, Cleveland Clinic, Johns Hopkins, and Stanford. With a background spanning IIT Delhi, University of Chicago Booth, investment banking at Bank of America Merrill Lynch, and healthcare consulting at Booz & Company, Jain built Carrum to solve a systemic problem: employers spending $20,000+ per employee annually on health benefits with up to a 10x pricing variation for identical procedures.
Anandan Chinnalagu is a PhD computer scientist and serial technology entrepreneur leading MindPro Technologies, an AI-focused software development firm headquartered in Karur, Tamil Nadu, India, with personal base in Sunnyvale, California. With over two decades of building enterprise software companies - from founding AC INFOTECH INC in 2003 to steering MindPro's 110-person team - he specializes in machine learning, natural language processing, and Google Cloud AI integrations. His academic research in sentiment analysis has been published in PeerJ Computer Science and IJACSA, while his products span educational platforms, IoT consulting, and notification automation under the CanString brand.
David Marks is the founder, President, and CEO of TEECOM, a California-based technology design and engineering firm he built from a one-man operation into a 200+ person global consultancy over nearly three decades. Starting at the Moscone Convention Center expansion in San Francisco, he has since shaped the technology infrastructure of hospitals, Fortune 500 offices, universities, and civic institutions across the U.S., EMEA, and APAC. A licensed Professional Engineer with credentials in communications distribution, design technology, and LEED, Marks is known for his belief that buildings should work as hard as the people inside them - and that the best technology is the kind you never notice.
Khanh Nguyen is the CEO of Cozeva, the operating system for value-based care that manages over 25 million lives across 97,000+ providers. A PharmD from UCSF with 15+ years pioneering payer-provider collaboration, she led Cozeva to a reported $480M merger with Vatica Health in 2025, combining the #1-rated Best in KLAS risk adjustment platform with Cozeva's #1 quality platform - creating the most comprehensive value-based care enablement company in the U.S.
Anuj Khandelwal is the CEO and Co-Founder of Empo Health, a San Bruno, CA-based medical device company developing in-home monitoring systems to prevent diabetic foot amputations. With a BS in Mechanical Engineering from MIT and MS in Mechanical Engineering (Medical Devices) from Stanford, Khandelwal founded Empo Health in 2020 alongside co-founder Eric Dahlseng. The company's flagship product — Empo Footprint, an FDA-listed in-home imaging scale — lets diabetic patients monitor foot health from home, transmitting images to care teams for early intervention. In June 2025, Empo Health raised a $7 million round led by Story Ventures to commercialize its remote diabetic foot ulcer management system.
Mark Lee, MD, PhD is the CEO and Co-Founder of N-Power Medicine, a Redwood City-based company reinventing how oncology clinical trials reach patients. A medical oncologist and scientist trained at Stanford and Harvard, Lee has spent his career at the frontier of personalized medicine - from developing Oncotype DX diagnostics at Genomic Health, to helping build early cancer detection at GRAIL, to leading personalized healthcare at Genentech/Roche. In 2021, he co-founded N-Power Medicine to embed research infrastructure directly into community oncology clinics, combining AI, embedded staff, and real-time registries to dramatically expand clinical trial access. After raising a $72M Series B led by Merck's Global Health Innovation Fund, N-Power acquired Syapse in late 2024 to build the largest community-based prospective clinical research network in oncology.